title: Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responses.
abstract: We show here that it is possible to combine two different genetic immunogens, one designed to induce HIV-1 specific humoral immune responses (pKCMVgp160B) and one designed to induce cellular anti-HIV-1 immune responses (Auxo-GTU-MultiHIV), and still retain the major properties of both vaccine constructs. The two different constructs were delivered using two different methods; the gene-gun and the Biojector, which both are needle-free devices. In BALB/c mice we were able to induce high levels of HIV-1-specific T cell responses as well as high levels of anti-gp160 antibodies by co-administrating the vaccine constructs. The cellular immune responses, but not antibody responses, were moderately compromised from the combination. This study shows that it is a feasible strategy to combine different vaccines and modes of delivery, but that interference as to magnitude may occur to certain gene products.
authors.affiliation: Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet and Swedish Institute for Infectious Disease Control, Stockholm, Sweden. andreas.brave@smi.se
authors.forename: Andreas
authors.initials: A
authors.lastname: Bråve
authors.forename: David
authors.initials: D
authors.lastname: Hallengärd
authors.forename: Maria
authors.initials: M
authors.lastname: Malm
authors.forename: Vesna
authors.initials: V
authors.lastname: Blazevic
authors.forename: Erik
authors.initials: E
authors.lastname: Rollman
authors.forename: Ioana
authors.initials: I
authors.lastname: Stanescu
authors.forename: Kai
authors.initials: K
authors.lastname: Krohn
mesh_terms: D016915:AIDS Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology; D000818:Animals; D019470:Biolistics; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000276:immunology; D015483:HIV Antibodies / Q000097:blood; D019302:HIV Envelope Protein gp160 / Q000276:immunology; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D015497:HIV-1 / Q000276:immunology*; D007114:Immunization; D007271:Injections, Intradermal; D007277:Injections, Jet / Q000295:instrumentation / Q000379:methods; D051379:Mice; D008807:Mice, Inbred BALB C; D013601:T-Lymphocytes / Q000276:immunology; D019444:Vaccines, DNA / Q000008:administration & dosage* / Q000235:genetics / Q000276:immunology*
chemical_list: D016915:AIDS Vaccines; D015483:HIV Antibodies; D019302:HIV Envelope Protein gp160; D019444:Vaccines, DNA; D016178:Granulocyte-Macrophage Colony-Stimulating Factor